Ronald D. Perrone

Also affiliated with Tufts Medical Center

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Pansomatostatin Agonist Pasireotide Long-Acting Release for Patients with Autosomal Dominant Polycystic Kidney or Liver Disease with Severe Liver Involvement”.

Pansomatostatin Agonist Pasireotide Long-Acting Release for Patients with Autosomal Dominant Polycystic Kidney or Liver Disease with Severe Liver Involvement

Clinical Journal of the American Society of Nephrology(2020)10.2215/cjn.13661119

N/A

1.2DataRank · unranked

38 citations

Julie A. Chamberlin, Lisa E. Vaughan, Angela L. Waits, Carly J. Banks, Kathleen Leistikow +10 more

Baseline Characteristics and Patient-Reported Outcomes of ADPKD Patients in the Multicenter TAME-PKD Clinical Trial

Kidney360(2020)10.34067/kid.0004002020

N/A

0.621DataRank · unranked

13 citations

Terry Watnick, Andrew D. Althouse, Ronald D. Perrone, Kaleab Z. Abebe, Kenneth R. Hallows +3 more

A meta-analysis of GFR slope as a surrogate endpoint for kidney failure

Nature Medicine(2023)10.1038/s41591-023-02418-0

N/A

0DataRank · unranked

160 citations

Willem Collier, Tom Greene, Shiyuan Miao, Juhi Chaudhari, Gerald B. Appel +79 more

A meta-analysis of randomized controlled clinical trials for implications of acute treatment effects on glomerular filtration rate for long-term kidney protection

Kidney International(2024)10.1016/j.kint.2024.05.024

N/A

0DataRank · unranked

12 citations

Devin Eddington, Juhi Chaudhari, Raymond O. Estacio, Enyu Imai, Marián Goicoechea +16 more

Effect of Dual RAAS Blockade and Intensive BP Lowering on Risk of End-Stage Kidney Disease and Death in Autosomal Dominant Polycystic Kidney Disease: Long-term Follow-up of the HALT-PKD Trials

American Journal of Kidney Diseases(2024)10.1053/j.ajkd.2024.06.020

N/A

0DataRank · unranked

6 citations

Timothy P. Copeland, Charles E. McCulloch, Kaleab Z. Abebe, Michel Chonchol, Ronald D. Perrone +6 more

KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary

Kidney International(2025)10.1016/j.kint.2024.07.010

N/A

0DataRank · unranked

96 citations

Curie Ahn, Thijs R.M. Barten, Godela Brosnahan, Melissa A. Cadnapaphornchai, Arlene B. Chapman +25 more

Toward Patient-Centered Innovation

Clinical Journal of the American Society of Nephrology(2020)10.2215/cjn.00110120

N/A

0DataRank · unranked

10 citations

Tandrea Hilliard, Kourtney Ikeler, San Keller, Debbie S. Gipson, Amanda Grandinetti +8 more

Qualitative Analysis and Comparison of Externally Led Patient-Focused Drug Development Concepts for Autosomal Recessive Polycystic Kidney Disease Against SONG Initiatives

Kidney Medicine(2025)10.1016/j.xkme.2025.101110

N/A

0DataRank · unranked

0 citations

Sorin V. Fedeles, Wendy Ruyle, Elise Hoover, Max C. Liebau, Erum A. Hartung +5 more

Association of Longitudinal Urinary Metabolic Biomarkers With ADPKD Severity and Response to Metformin in TAME-PKD Clinical Trial Participants

Kidney International Reports(2022)10.1016/j.ekir.2022.11.019

N/A

0DataRank · unranked

14 citations

Kaleab Z. Abebe, Hui Li, B. Saitta, Andrew D. Althouse, Kyongtae T. Bae +6 more